What is the appropriate management for a 26-year-old female with dengue shock syndrome who is intubated for severe dyspnea and remains hypotensive and tachycardic despite an initial fluid challenge?

Management of Dengue Shock Syndrome with Refractory Hypotension

In this 26-year-old female with dengue shock syndrome who remains hypotensive and tachycardic despite initial fluid challenge, you must immediately initiate vasopressor support while carefully reassessing fluid responsiveness before administering additional fluids, and avoid excessive cumulative fluid administration (>8L) which is strongly associated with mortality in dengue shock.

Immediate Hemodynamic Management

Vasopressor Initiation

• Start vasopressors immediately to target a mean arterial pressure (MAP) ≥65 mmHg 1, 2
• Do not delay vasopressor therapy while continuing futile fluid boluses in a patient already demonstrating fluid non-responsiveness
• The 2025 ESICM guidelines emphasize early hemodynamic stabilization with both fluids and vasopressors as needed 1

Fluid Responsiveness Assessment

Before administering any additional fluids, you must assess fluid responsiveness 1:

• Perform a fluid challenge (200-500 mL over 5-10 minutes) while actively monitoring response 1
• Use dynamic variables (pulse pressure variation, stroke volume variation) rather than static measures when available 2
• Monitor cardiac output changes and pulse pressure rather than MAP alone to assess fluid bolus effectiveness 1
• Evaluate tissue perfusion markers: capillary refill time, skin mottling, lactate clearance 1

Critical caveat: In dengue shock syndrome specifically, fluid responsiveness assessment is paramount because the pathophysiology involves transient capillary leak, not pure hypovolemia 3, 4.

Fluid Management Strategy - The Dengue-Specific Approach

Avoid Excessive Fluid Accumulation

The most recent and highest quality evidence demonstrates that cumulative fluid balance >8L is independently associated with 6.7-fold increased mortality risk in dengue shock syndrome (OR 6.682,95% CI 1.808-24.689, P=0.004) 5. This 2025 Pakistani study of 135 DSS patients showed:

• Survivors had median cumulative fluid balance of 1,493 mL
• Non-survivors had median cumulative fluid balance of 7,797 mL
• High SOFA scores and >8L cumulative fluid were the only independent mortality predictors 5

Judicious Fluid Administration Protocol

• If fluid responsive: Give small boluses (200-500 mL) with frequent reassessment 1
• Titrate carefully even in fluid-responsive patients, especially with elevated filling pressures 1
• Monitor for signs of fluid overload: rising intravascular filling pressures, extravascular lung water, declining PaO₂/FiO₂ ratio, lung ultrasound changes 1

Colloid Considerations

While some older literature suggested colloids for refractory dengue shock 6, more recent evidence from 2025 shows significant harm:

• Mixed crystalloid/colloid initial resuscitation increased respiratory compromise (HR 2.08), need for ventilation (OR 2.34), and hospital days (RR 1.33) 3
• Liberal colloid use (>4 hours) increased respiratory compromise (OR 8.84) and ventilation requirements (OR 8.16) despite reducing recurrent shock 3
• Use crystalloids only for initial resuscitation; reserve colloids only for truly refractory shock unresponsive to vasopressors 3, 4

Monitoring for Complications

Cardiac Function Assessment

This intubated patient requires echocardiographic evaluation because:

• Dengue can cause acute myocarditis with severe systolic dysfunction 7
• Lower stroke volume index on admission predicts recurrent shock 8
• Cardiac dysfunction changes fluid management strategy dramatically - fluid overload in dengue myocarditis causes decompensation 7
• Higher left ventricular myocardial performance index on days 3-5 associates with respiratory distress 8

Lactate Monitoring

• Admission lactate predicts recurrent shock and correlates with total fluid requirements 8
• Target lactate normalization as a resuscitation endpoint 2
• Elevated lactate (>4 mmol/L) in this patient indicates severe tissue hypoperfusion requiring aggressive hemodynamic optimization

Respiratory Management Considerations

Since this patient is already intubated for severe dyspnea:

• Anticipate worsening respiratory status with any additional fluid administration 5, 3
• Respiratory failure is the most common reason for intubation in DSS (48.2% of cases) 5
• Excessive fluid is directly associated with respiratory distress in dengue 8, 3

Algorithmic Approach Summary

1. Immediate: Start vasopressors targeting MAP ≥65 mmHg
2. Assess fluid responsiveness before any additional fluid boluses using dynamic variables and cardiac output monitoring
3. If fluid responsive: Give 200-500 mL crystalloid bolus, reassess immediately
4. If NOT fluid responsive: Optimize vasopressor therapy, do NOT give more fluid
5. Obtain echocardiogram to assess cardiac function and guide management
6. Monitor cumulative fluid balance - actively consider fluid removal strategies if approaching 3.5-8L cumulative positive balance
7. Frequent reassessment (every 30 minutes to hours) as hemodynamic instability may recur 1

The fundamental principle: In dengue shock syndrome, the capillary leak is transient and self-limited. Aggressive fluid resuscitation beyond what is needed for immediate hemodynamic stabilization causes harm through fluid overload, respiratory failure, and increased mortality 5, 3, 4.